The NSUN2 inhibitor NSUN2-i4 significantly enhances the efficacy of PD-1 against colorectal cancer without causing significant toxicity, indicating that NSUN2 is has promise as a target for cancer immunotherapy combined with an immune checkpoint inhibitor (ICI) 197. This evidence concerns the gene NSUN2 and colorectal cancer.